Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by losingmyshirt on Jan 06, 2022 10:40am

Sad but true.

@malarkey Fake News Clitaris Announces Strategy for the Nitric Oxide Formula R812 for Enhanced Orgasms and Increased Sexual Desire. Sanfrancisco, CA and Toronna, On Jan 2022 Clitaris -- Stockgroup CLYt are pleased to announce plans for another new strategy to develop R812, this time for the enhancement of sexual pleasure. “CLYT is poised to accelerate the development of R812 so that soon both men and women can expect bigger and better orgasms.” Said Director LMShirt Phase 1 Study will be complete after it commences sometime this year, stay tooned. Phase 2 which is a multiple will commence sometime after Phase 1 is completed Phase 2C will be a multiple phase focussing on making it easier for men to achieve and maintain erections while women will experience increased natural lubrication. Mister Shirt continued “ Nitric oxide can have sexual health benefits, improve cardiovascular health, promote energy level and moods, improve function and expedite recovery time.(wink, wink ) This is certainly what the world needs now” The Salesman Team were going to volunteer gratis but later decided to negotiate another Licence and have begun making room so that their sharecount is again less than 19%
Comment by AngelaL on Jan 06, 2022 11:53am
There is of course a vast literature on the nitric oxide pathway in sexual dysfunction. Viagra, for example, works by stabilizing cGMP which is induced by endogenous nitric oxide. For female sexual dysfunction there is also a growing scientific literature, since the erectile function of the clitoris and the lubrication of the vagina are mediated by endogenous nitric oxide stimulation of cGMP. I ...more  
Comment by Red~One on Jan 06, 2022 9:50pm
Whew, thanks for sharing
Comment by PTBailey on Jan 06, 2022 12:12pm
Serious question, if Claritas comes out with financial and start of phase one announcement will you still bash it?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities